Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Colorectal Dis. 2012 Jul;14(7):866-71. doi: 10.1111/j.1463-1318.2011.02808.x.
Long-term results of the overlapping sphincter repair (OSR) have been disappointing, attributed to poor tissue quality that deteriorates with time. Biological grafts enforce tissues. The aim was to compare functional outcome and quality of life at 1 year with and without Permacol reinforcement to evaluate short-term benefit.
From November 2007 to November 2008, women undergoing OSR using Permacol (group 1, n = 10) under institutional review board approval (safety trial) were age matched with patients from an institutional review board approved database (group 2, n = 10) who underwent the traditional OSR. Permacol mesh was placed under the two overlapped muscles. Group 2 underwent traditional repair. Preoperative and postoperative management of the groups was similar. The Fecal Incontinence Severity Index (FISI), the Cleveland Clinic Incontinence Score (CCFIS) and the Fecal Incontinence Quality of Life (FIQL) scale were used preoperatively and 1 year post-surgery.
No significant differences in demographics, symptom duration, number of vaginal deliveries, comorbidities and symptom severity were noted. Group 2 underwent concomitant procedures. Group 1 reported no complications. Group 2 reported urinary retention and dehiscence. A significant difference was found in preoperative and postoperative FIQL subscales of coping/behaviour between groups. However, comparing the pre and post scores, significant improvements on FISI (P = 0.02), the CCFIS (P = 0.005) and two subscales of FIQL (coping/behaviour, P = 0.02, and embarrassment, P = 0.01) were found in group 1. Patient satisfaction was higher in group 1.
Biologic tissue enhancers (Permacol) do not add morbidity. Sphincter augmentation results in significant improvement in continence and quality of life scores compared with the preoperative scores in the short term over traditional repair. Long-term studies are needed to determine if this effect is sustained.
重叠括约肌修复术(OSR)的长期效果并不理想,这归因于组织质量随着时间的推移而恶化。生物移植物可强化组织。本研究旨在对比分析使用 Permacol 加强重叠括约肌修复术(OSR)的短期临床效果,并评估其对功能结果和生活质量的影响。
在机构审查委员会批准下(安全试验),2007 年 11 月至 2008 年 11 月,10 例女性患者接受了 Permacol 重叠括约肌修复术(OSR)(组 1)。同时,从机构审查委员会批准的数据库中匹配年龄相同的 10 例接受传统 OSR 的患者作为对照组(组 2)。Permacol 网片置于重叠的两块肌肉下方。组 2 行传统修复术。两组患者的术前和术后管理均相似。术前和术后 1 年分别采用粪便失禁严重程度指数(FISI)、克利夫兰临床失禁评分(CCFIS)和粪便失禁生活质量(FIQL)量表进行评估。
两组患者在人口统计学、症状持续时间、阴道分娩次数、合并症和症状严重程度等方面均无显著差异。组 2 患者同时进行了其他手术。组 1 患者未发生并发症,而组 2 患者报告出现了尿潴留和切口裂开。两组患者 FIQL 量表的应对/行为子量表在术前和术后有显著差异。然而,比较术前和术后评分,组 1 患者的 FISI(P = 0.02)、CCFIS(P = 0.005)和 FIQL 量表的两个子量表(应对/行为,P = 0.02;尴尬,P = 0.01)显著改善。组 1 患者的满意度更高。
生物组织增强剂(Permacol)不会增加发病率。与传统修复术相比,括约肌强化术在短期内可显著改善控便能力和生活质量评分,且优于术前水平。需要进行长期研究以确定这种效果是否持久。